Oncodesign Services News Today

/PRNewswire/ -- The global drug discovery outsourcing market size is estimated to grow by USD 1.79 bn from 2024-2028, according to Technavio. The market is...

26.03.2024 - Regulatory News: Oncodesign Precision Medicine (OPM) (ISIN: FR001400CM63; Mnemonic: ALOPM), a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancer, has published its financial results for ...

On Tuesday, investment group Eurazeo announced that it had acquired a stake in Oncodesign Services, a company specializing in drug discovery and pre-clinical services in oncology and...

DUBLIN--(BUSINESS WIRE)--The "Drug Discovery Services Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global drug discovery services market is set to witness significant growth with a promising future in the pharmaceutical & biotechnolo...

/PRNewswire/ -- The "Drug Discovery Services Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to...

Drug Discovery Services Market is expected to reach $37.3 Billion by 2028- An exclusive market research report by Lucintel

This article describes the term long COVID-19 as a complication after the experience of the infection, and how it can be mimicked for drug discovery.

This article examines the advantages of digital PCR (dPCR) over traditional quantitative PCR (qPCR). Discover how dPCR is revolutionizing various fields, including genetic research, medical diagnostics, and oncology.

This article describes the evolving landscape of covalent binders in the pharmaceutical industry. Oncodesign Services presents its extensive library of benzoxaboroles, a novel class of covalent binders, revolutionizing drug discovery with nearly 300 compounds available for screening.

This article discusses the importance of gut microbes in human health and diseases and how they talk to different organs.